Ten63 Therapeutics Raises $15.9 Million in Oversubscribed Series A Financing to Drug the Undruggables by Combining the Power of AI and Physics-based Models
May 02, 2023 07:30 ET
|
Ten63 Therapeutics
Ten63’s foundation is built on research developed by world-renowned computational scientists at Duke University Proprietary BEYOND platform searches over 100 trillion synthetically feasible...
Ribometrix Raises $7.5 Million in Seed Funding to Advance Platform for Discovering and Developing Small Molecule Modulators of RNA to Treat Human Diseases
October 31, 2017 09:00 ET
|
Ribometrix
DURHAM, NC--(Marketwired - Oct 31, 2017) - Ribometrix, Inc., a biotech company dedicated to discovering and developing small molecule modulators of RNA to treat disease, has raised $7.5 million in...